Abstract
The emergence of a large number of new cases, as well as cellular resistance to multiple drugs, have been a challenge in the fight against several types of cancer. One of the strategies to overcome this challenge is the development of new drugs that combine drugs currently available in the clinic (or under clinical tests) and metals with recognized cytotoxic activities. Uracil derivatives…